348 related articles for article (PubMed ID: 26071673)
1. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial.
Shaaban OM; Ali MK; Sabra AM; Abd El Aal DE
Contraception; 2015 Oct; 92(4):301-7. PubMed ID: 26071673
[TBL] [Abstract][Full Text] [Related]
2. Comparison of combined transcervical resection of the endometrium and levonorgestrel-containing intrauterine system treatment versus levonorgestrel-containing intrauterine system treatment alone in women with adenomyosis: a prospective clinical trial.
Zheng J; Xia E; Li TC; Sun X
J Reprod Med; 2013; 58(7-8):285-90. PubMed ID: 23947077
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.
Fong YF; Singh K
Contraception; 1999 Sep; 60(3):173-5. PubMed ID: 10640162
[TBL] [Abstract][Full Text] [Related]
4. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
Kelekci S; Kelekci KH; Yilmaz B
Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
[TBL] [Abstract][Full Text] [Related]
5. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
Park DS; Kim ML; Song T; Yun BS; Kim MK; Jun HS; Seong SJ
Taiwan J Obstet Gynecol; 2015 Aug; 54(4):412-5. PubMed ID: 26384061
[TBL] [Abstract][Full Text] [Related]
6. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
Sheng J; Zhang WY; Zhang JP; Lu D
Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
[TBL] [Abstract][Full Text] [Related]
7. Comparison of efficacy between levonorgestrel intrauterine system and dienogest in adenomyosis: a randomized clinical trial.
Choudhury S; Jena SK; Mitra S; Padhy BM; Mohakud S
Ther Adv Reprod Health; 2024; 18():26334941241227401. PubMed ID: 38283750
[TBL] [Abstract][Full Text] [Related]
8. Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system.
Li L; Leng J; Jia S; Lang J
Int J Gynaecol Obstet; 2019 Sep; 146(3):357-363. PubMed ID: 31194884
[TBL] [Abstract][Full Text] [Related]
9. [Levonorgestrel-releasing intrauterine system and combined oral contraceptives as conservative treatments for recurrent ovarian endometriosis: a comparative clinical study].
Xu XW; Wang LD; Zhu XQ; Yan LZ; Guan YT; Zhu SC; Hu Y
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(15):1047-50. PubMed ID: 21609640
[TBL] [Abstract][Full Text] [Related]
10. The role of levonorgestrel intra-uterine system in the management of adenomyosis: A systematic review and meta-analysis of prospective studies.
Abbas AM; Samy A; Atwa K; Ghoneim HM; Lotfy M; Saber Mohammed H; Abdellah AM; El Bahie AM; Aboelroose AA; El Gedawy AM; Mostafa M; Elsenity MA; Samy M; Safwat S; Abdelrahman RM; Salah El Din AS; Badran E; Abdelkader AM; Abdallah A
Acta Obstet Gynecol Scand; 2020 May; 99(5):571-581. PubMed ID: 31889294
[TBL] [Abstract][Full Text] [Related]
11. [A prospective cohort study on effects of levonorgestrel-releasing intrauterine system for adenomyosis with severe dysmenorrhea].
Li L; Leng JH; Dai Y; Zhang JJ; Jia SZ; Li XY; Shi JH; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):345-51. PubMed ID: 27256441
[TBL] [Abstract][Full Text] [Related]
12. The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
Costanzi F; De Marco MP; Colombrino C; Ciancia M; Torcia F; Ruscito I; Bellati F; Frega A; Cozza G; Caserta D
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3432-3439. PubMed ID: 34002816
[TBL] [Abstract][Full Text] [Related]
13. Effects of levonorgestrel-releasing intrauterine system on lymphangiogenesis of adenomyosis.
Cho S; Choi YS; Yun BH; Chon SJ; Jung YS; Kim H; Park JH; Seo SK; Kim SH; Lee BS
Am J Clin Pathol; 2015 Mar; 143(3):352-61. PubMed ID: 25696793
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis.
Zhang P; Song K; Li L; Yukuwa K; Kong B
Med Princ Pract; 2013; 22(5):480-3. PubMed ID: 23796720
[TBL] [Abstract][Full Text] [Related]
15. Levonorgestrel-Releasing Intrauterine System Improves Menorrhagia-Related Quality of Life in Patients with Symptomatic Adenomyosis.
Ishizawa C; Hirota Y; Iida R; Kaku T; Hirata T; Fukui Y; Omura E; Akaeda S; Hiraoka T; Matsuo M; Osuga Y
Reprod Sci; 2023 Mar; 30(3):966-973. PubMed ID: 36071343
[TBL] [Abstract][Full Text] [Related]
16. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
[TBL] [Abstract][Full Text] [Related]
17. A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia.
Sayed GH; Zakherah MS; El-Nashar SA; Shaaban MM
Int J Gynaecol Obstet; 2011 Feb; 112(2):126-30. PubMed ID: 21092958
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of high-intensity focused ultrasound combined with LNG-IUS for adenomyosis: a systematic review and meta-analysis.
Zhao TT; Pang LL; Yang LL; Li RN; Fan LX; Wen Y
Arch Gynecol Obstet; 2023 Aug; 308(2):351-362. PubMed ID: 35947146
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging.
Bragheto AM; Caserta N; Bahamondes L; Petta CA
Contraception; 2007 Sep; 76(3):195-9. PubMed ID: 17707716
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and safety of levonorgestrel releasing intrauterine system in the treatment of adenomyosis: evidence mapping.
Shi J; Gu Z; Wu Y; Li X; Zhang J; Zhang C; Yan H; Dai Y; Leng J
Arch Gynecol Obstet; 2024 Jul; 310(1):55-67. PubMed ID: 38836931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]